FDA Inspection
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA Inspection, Oct 21, 2016
Record Details
This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on October 21, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 9a41f385-bd40-454e-bfcf-1cf95a896584
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 994781
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Therapeutics LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| September 1, 2023 | Not classified | Atlanta District Office | |
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2017 | Not classified | Atlanta District Office |
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.